The Blacklegged Tick, Ixodes scapularis: An Increasing Public Health Concern.
The Blacklegged Tick, Ixodes scapularis: An Increasing Public Health Concern. Trends Parasitol. 2018 Jan 11;: Authors: Eisen RJ, Eisen L Abstract In the United States, the blacklegged tick, Ixodes scapularis, is a vector of seven human pathogens, including those causing Lyme disease, anaplasmosis, babesiosis, Borrelia miyamotoi disease, Powassan virus disease, and ehrlichiosis associated with Ehrlichia muris eauclarensis. In addition to an accelerated rate of discovery of I. scapularis-borne pathogens over the past two decades, the geographic range of the tick, and incidence and range of I. scapularis-borne disease cases, have increased. Despite knowledge of when and where humans are most at risk of exposure to infected ticks, control of I. scapularis-borne diseases remains a challenge. Human vaccines are not available, and we lack solid evidence for other prevention and control methods to reduce human disease. The way forward is discussed. PMID: 29336985 [PubMed - as supplied by publisher]
Chem. Commun., 2019, Accepted Manuscript DOI: 10.1039/C8CC08622B, CommunicationChang-xin Huo, Debashis Dhara, Scott Baliban, Setare Tahmasebi Nick, Zibin Tan, Raphael Simon, Anup Kumar Misra, Xuefei Huang The first synthetic carbohydrate based potential anti-Salmonella Enteritidis vaccine has been developed by conjugating a synthetic tetrasaccharide antigen with bacteriophage Q β. High levels of specific and long lasting anti-glycan IgG... The content of this RSS Feed (c) The Royal Society of Chemistry
A panel to promote an alternative explanation for climate change would be disastrous. Yet that ’s what White House officials wantAmericans should not be fooled by the Stalinist tactics being used by the White House to try to discredit the findings of mainstream climate science.The Trump administration has alreadypurged information about climate change from government websites,gagged federal experts and attempted toend funding for climate change programmes.Continue reading...
Research ArticlesL. KRBKOV Á, L. HOMOLA, A. HLAVÁČOVÁ, P. MIKOLÁŠEK, J. BEDNÁŘOVÁ, Z. ČERMÁKOVÁ,Epidemiology&Infection,Volume 144 Issue 12, pp 2597-2604Abstract
Article CommentaryFrederick M. Burkle,Disaster Medicine and Public Health Preparedness,Volume 10 Issue 04, pp 531-535Abstract
Research ArticlesAnat Gesser-Edelsburg, Yaffa Shir-Raz, Oshrat Sassoni Bar-Lev, James J. James, Manfred S. Green,Disaster Medicine and Public Health Preparedness,Volume 10 Issue 04, pp 669-673Abstract
Research ArticlesRalph J. Coates, Alejandro P érez, Atar Baer, Hong Zhou, Roseanne English, Michael Coletta, Achintya Dey,Disaster Medicine and Public Health Preparedness,Volume 10 Issue 04, pp 562-569Abstract
Research reveals striking changes in babies ’ immune development that could form the basis for lifesaving vaccinesA groundbreaking study has claimed that the key to saving the lives of newborns is found in just half a teaspoon of blood.Research has revealed dramatic changes in the immune systems of newborns, which scientists say could transform our understanding of disease in babies.Continue reading...
Authors: Ohno T, Miyasaka Y, Kuga M, Ushida K, Matsushima M, Kawabe T, Kikkawa Y, Mizuno M, Takahashi M Abstract Malaria is caused by Plasmodium parasites and is one of the most life-threatening infectious diseases in humans. Infection can result in severe complications such as cerebral malaria, acute lung injury/acute respiratory distress syndrome, and acute renal injury. These complications are mainly caused by P. falciparum infection and are major causes of death associated with malaria. There are a few species of rodent-infective malaria parasites, and mice infected with such parasites are now widely used for s...
Pancreatic cancer is the third leading cause of death related to cancer in the United States. In contrast to colorectal, breast, and lung cancer, the number of cases are increasing, with pancreatic cancer predicted to become the second most common cause of death due to cancer by 2030.1 The 5-year survival for pancreatic cancer is an abysmal 8.5%.2 One key to improving survival in pancreatic cancer is detecting cancer earlier, with some studies demonstrating survival of almost 60% in patients with stage I cancer.
Esophageal cancer is the eighth most common cancer worldwide and represents the sixth leading cause of global cancer mortality.1 Although esophageal adenocarcinoma (EAC) now accounts for the majority of esophageal cancer diagnosed in the United States, esophageal squamous cell carcinoma (ESCC) remains far more prevalent worldwide. The International Agency for Research on Cancer estimates that 88% of esophageal cancer cases in 2012 were ESCC, with only 12% representing EAC. ESCC exhibits a striking regional variation in incidence, both globally and within a single nation.